
Develops CE-certified point-of-care tests for molecular diagnostics, e.g. the Venus GTest for gynecology.

BioMS GmbH Molecular Science
BremenNew on Amplifa
About BioMS
BioMS GmbH Molecular Science is a medical technology company founded in 2018 and based at Fahrenheitstraße 1 in Bremen. The company develops a point-of-care platform technology based on molecular diagnostics with applications in gynecology, infectious diseases, oncology and veterinary medicine. The first application is the CE-certified Venus GTest™, which detects the three most common vaginal infections – bacterial vaginosis, trichomoniasis and candidiasis – simultaneously in around one minute from a single swab. According to LinkedIn, the company employs 2–10 people and exhibited at the Arab Health trade fair in Dubai in 2019 and 2020. The Medical Director is Dr. Saman F. Alhowaizy.
- Site
- Bremen
- Processes
- POC molecular diagnostics (point of care), Venus G Test™ – detection of bacterial vaginosis, trichomoniasis and candidiasis in ~1 minute, Point-of-care tests for women's health (Venus GTest: detection of bacterial vaginosis,, Molecular diagnostics platform technology with applications in gynecology, infectious diseases,
- Materials
- Molecular Point-of-Care Diagnostics (IMS Technology)
- Certificates
- CE certification (Venus GTest), CE Certification (Venus GTest™)
- Founded
- 2018
- Employees
- 2–10
- Industries
- Medical Technology, Gynecology / Women's Health, Infectious Disease Diagnostics, Oncology, Veterinary Diagnostics, Medical Technology (Manufacturing of Medical Devices)
- 01
Research & development of the diagnostics platform
- 02
Manufacturing of the test kits
- 03
Quality assurance/CE certification
- 04
Distribution of the point-of-care tests
Technology & Processes
Molecular Point-of-Care Diagnostics (IMS Technology)
Platform technology for the rapid detection of infections from a single swab in approx. one minute.
Locations
Bremen
DEHeadquarters
Products

Inside the production

Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| POC molecular diagnostics (point of care)Testing | – | – | – | – | – |
| Venus G Test™ – detection of bacterial vaginosis, trichomoniasis and candidiasis in ~1 minuteTesting | – | – | – | – | – |
Additional services
Quality
The Venus GTest™ is CE-certified; the test detects the three most common vaginal infections simultaneously from a single swab.
| Evidence | Bremen |
|---|---|
| CE Certification (Venus GTest™) |
History
- 2018
Company founded according to LinkedIn
- 2019
Exhibitor at Arab Health, Dubai World Trade Centre (booth Z2.K54)
- 2020
Participation in Arab Health again (booth Z2.K54)